4th Quarter - Amendment

340B HEALTH for 340B HEALTH

Firm
Client
Income
—
Expenses
$224,795
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

HR 2606 and S 1376. Extending 340B Drug Pricing to Inpatient Setting in DSH Hospitals and improving program integrity. Preserving current 340B Patient Definition Opposition to new regulations regarding physician administered drugs

LobbyistCovered position, as disclosed
STUART YAEL GORDON —
ANNA MANGUM LA for Reps Viscloskey and Fascell 88-91
ROBERT RECKLAUS Chief of Staff for Rep. Carolyn McCarthy 02-08
TED SLAFSKY Fellow for Sen. Dem. Policy Committee 1994
JAIMIE VICKERY LA for Reps Horn and Biggert 2000-05
WILLIAM VON OEHSEN —
BONNIE WEINTRAUB —

Contacted: Health Resources & Services Administration (HRSA); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE; Office of Management & Budget (OMB)

Bills named: H.R. 2606 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.